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A B S T R A C T   
A significant dysfunction of another organ is usually considered an absolute contraindication for lung trans-
plantation, unless multiorgan transplantation is indicated and practical, as is the case of combined lung-kidney 
transplantation. Few cases of combined lung-kidney transplantation have been described in the literature; 
however, it is known that, in certain cases, it is the only way to offer an opportunity to selected patients with 
renal and lung dysfunction. The authors are not aware of any previously published case of a patient receiving 
both extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration as a bridge for 
combined kidney-lung transplantation. 
The authors present the first case of combined lung-kidney transplantation performed in Portugal.   
1. Case report 
The authors present the case of a 29-year-old woman, diagnosed with 
cystic fibrosis at the age of 3 (homozygous for F508del), with exocrine 
pancreatic insufficiency and pansinusitis. She has been monitored as a 
pre-transplantation consultation since June 2016, with extensive cystic 
bronchiectasis (Fig. A1 and A2) with Pseudomonas aeruginosa and 
Aspergillus fumigatus colonization, as well as multiple hospitalizations for 
respiratory infections. At the time of admission, she weighed 52 kg was 
165 cm tall and had Forced Expiratory Volume in 1 second (FEV1) of 
720 cc (21%) and Total Lung Capacity (TLC) of 3650 cc (79%). She was 
also hypoxemic, requiring oxygen support therapy. The patient entered 
the list for lung transplantation in February 2017, with low priority, due 
to her clinical and functional stability. For better understanding, we 
perform a timeline (Table 1). 
To investigate the appearance of nephrotic proteinuria in February 
2018, she underwent a renal biopsy that revealed deposits of amyloid A, 
and the diagnosis of AA amyloidosis (or secondary amyloidosis) was 
established. In October 2018, the patient was admitted to the Intensive 
Care Unit (ICU) for dehydration secondary to diarrhea, with subsequent 
acute renal failure and oligoanuria requiring continuous venovenous 
hemodiafiltration (CVVHDF). At the ICU, she developed a respiratory 
infection (Fig. B1 and B2) and septic shock requiring invasive mechan-
ical ventilation. Antibiotic therapy was started with ceftolozane/tazo-
bactam and ciprofloxacin considering an antibiotic sensitivity test (AST) 
positive for Pseudomonas aeruginosa infection. Due to worsening respi-
ratory failure, it was necessary to start venovenous extracorporeal 
membrane oxygenation (VV-ECMO). After failure of weaning from 
mechanical ventilation, the patient underwent tracheostomy, main-
taining invasive mechanical ventilation, awake-ECMO and CVVHDF. 
The absence of improvement in renal function granted formal indication 
for combined lung-kidney transplantation (CLKT). 
During the 32 days of ICU stay, 27 of them under “awake-ECMO,” the 
patient suffered hemothorax and hemopericardium secondary to anti-
coagulation, which evolved to cardiac arrest that was successfully 
reversed. Physical rehabilitation was limited at this point, and only in- 
bed mobilization exercises were feasible. 
On the 33rd day of the ICU stay, the patient was underwent CLKT. 
The donor was a 69-year-old woman, weighing 60 kg and measuring 171 
cm, with no relevant medical history. She had a predicted TLC of 
4050 cc. Her last arterial blood gas analysis had pO2 of 512 mmHg with 
FiO2 of 1.0 and a positive end-expiratory pressure of 5 cmH2O for 5 min. 
* Corresponding author. Pulmonology Department, Hospital of Santa Marta, Centro Hospitalar Universitário Lisboa Central (CHULC), Portugal. 
E-mail address: david.silva3@chulc.min-saude.pt (D.T. Silva).  
Contents lists available at ScienceDirect 
Respiratory Medicine Case Reports 
journal homepage: www.elsevier.com/locate/rmcr 
https://doi.org/10.1016/j.rmcr.2021.101386 
Received 26 January 2021; Received in revised form 2 March 2021; Accepted 12 March 2021   
Respiratory Medicine Case Reports 33 (2021) 101386
2
Tracheobronchial aspirate cultures were negative. The donor explants 
were performed in a multiorgan context without complications, and the 
lungs were preserved in Perfadex®. 
A sequential double-lung transplant was performed under venoar-
terial ECMO. It was very laborious because of the existence of bilateral 
empyema, which led to extrapleural pneumectomy with profuse hem-
orrhage, due to the patient’s hypocoagulant status. In total, one pro-
thrombin complex, 15 red cell concentrates, five platelet concentrates 
and four fresh frozen plasma units were required to support the patient. 
Ischemic times were 6 h 18 min for right lung and 8 h 13 min for left 
lung. After lung transplantation, kidney transplantation was performed, 
with an ischemic time of 11 h 57 min and no major complications noted, 
and good perfusion was observed after implantation. 
The immediate post-transplant period was complicated by multi-
factorial shock, requiring the restart of CVVHDF, high-dose vasopressor 
support (noradrenaline up to 2 μg/kg/min and dopamine up to 4 μg/ 
min), VV-ECMO and intensive fluid therapy. 
Immunosuppression included induction with 20 mg basiliximab on 
day 0 and day 4 of transplantation and maintenance therapy with 
tacrolimus, which was started during surgery (target blood levels 
around 10 ng/mL in the first 6 months and 6 ng/mL afterwards), mofetil 
mycophenolate and steroids. Corticosteroid therapy was started during 
the transplant, at the unclamping of each pulmonary artery, initially 
with methylprednisolone 500 mg I.V., continuing with the following 
Table 1 
Timeline. 
Legends: CLKT - Combined Lung-kidney transplantation; CVVHDF - Continuous venovenous hemodiafiltration; ICU - Intensive care unit; PT - Post- 
transplantantion; VA-ECMO - Venoarterial extracorporeal membrane oxygenation; VV-ECMO - Venovenous extracorporeal membrane oxygenation. 
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weaning schedule: 125 mg tid on day 1, 125 mg bid on day 2, and 125 
mg qd on day 3, with weaning of 10 mg per day down to a daily dose of 
0.5 mg/kg/day prednisolone for the first month after transplant and 
progressive weaning down to 0.1 mg/kg/day after the first month. 
She was started on empirical antibiotics with meropenem, as well as 
anidulafungin directed at Candida albicans and C. dubliniensis (isolated in 
the recipient’s bronchoalveolar lavage) and to previous isolations of A. 
fumigatus. Prophylaxis with inhaled colistin and prophylactic therapy for 
cytomegalovirus with ganciclovir (switched to valganciclovir at the end 
of the 14th day) were also carried out. 
There was slow improvement and complicated ventilatory weaning 
due to marked sarcopenia, which also motivated the assessment of renal 
function based on serum cystatin C rather than creatinine levels, esti-
mating a glomerular filtration rate of 25–35 mL/min. The patient was 
subsequently submitted to amputation of the left forearm, fourth and 
fifth toes of the left foot and distal phalanx of the fifth toe of the right 
foot due to irreversible ischemia, owing to the high aminergic support in 
the pre-operative, intra-operative and post-operative periods. In the first 
five days post-transplantation, rehabilitation exercises aimed to improve 
orthostatic positioning and passive limb mobilization. 
The discontinuation of VV-ECMO was only possible on day 5 post- 
transplant, while continuous dialysis was suspended on day 7 post- 
transplant. After this, she showed progress in the physical rehabilita-
tion program, and started resistance training with light weights, postural 
re-education and transfer to chair. Spontaneous ventilation was ach-
ieved on day 50, supplemental oxygen therapy was suspended on day 60 
and tracheostomy was removed on day 130 post-transplant. 
During her stay in the Transplant Unit, the patient also underwent 
multiple cycles of antibiotics for nosocomial infections, in addition to 
those previously described, namely 7 days of tigecycline directed at 
Klebsiella oxytoca isolated from a renal graft; 21 days of ceftazidime- 
avibactam and intravenous colistine, respectively, directed at Pandor-
aea and P. aeruginosa isolated in pleural fluid; fluconazole directed at C. 
parapsilosis in urine; and 15 days of cotrimoxazole and ceftriaxone to 
treat K. pneumoniae sepsis of urinary origin. 
Transfer to the Pulmonology ward took place on the 23rd day post- 
transplant. Serial renal Doppler ultrasonography was performed, 
which showed renal artery stenosis requiring stent placement (day 158 
post-transplant). 
At the ward, it was possible to start an intensive rehabilitation pro-
gram and occupational therapywith progressive gain of autonomy. The 
patient continued to perform resistance training with light weights, 
stretching and started to walk in the corridor. Only after the first 20 days 
in the ward, she did undergo respiratory and physical rehabilitation in 
the gym, where she started to do resistance training with progressively 
heavier weights, chest wall mobility and chest expansion exercises and 
walking on treadmill, with progressively higher speed settings. No 
additional complications, renal, pulmonary or otherwise, were 
identified. 
The patient was discharged from the hospital 186 days after the 
transplant and after 224 days of hospitalization, with FEV1 of 1790 cc 
(54%), FVC 2030 cc (52%) and DLCO 56% (KCO 84%), creatinine 2.31 
mg/dL, blood urea nitrogen 100 mg/dL, and cystatin C 2.64 mg/L, with 
an estimated GFR of 22 mL/min. 
She maintains follow-up on the kidney and lung transplant services. 
Twenty-four months after CLKT, the patient wears a forearm prosthesis. 
She denies any major complaints and presents with FEV1 2520 cc (74%), 
FVC 3420 cc (85%), creatinine 1.4 mg/dL, and blood urea nitrogen 38 
mg/dL, with an estimated GFR of 50 mL/min. 
2. Discussion 
The hospital of Santa Marta, in Lisbon, has been the lung trans-
plantation center of reference in Portugal since 1991, when the first 
combined heart-lung transplant was performed. It was only in 2001 that 
the first isolated lung transplantation took place. Twenty-one lung 
transplants were performed before 2008, when the team was reor-
ganized and new protocols were elaborated. Since then, more than 300 
lung transplantation have been performed, but, to date, no CLKT has 
never been carried out. 
In Portugal, cystic fibrosis is only the third leading cause of lung 
transplantation [1], and worldwide, it is the third most common cause 
for CLKT [2]. Although lung involvement is more characteristic, cystic 
fibrosis can also affect the pancreas, liver, kidneys and intestine. The 
evolution of the disease can be very variable; however, recurrent res-
piratory infections are common, which become more frequent 
throughout life. In the presented case, the successive infectious events 
promoted the deposition and accumulation of amyloid A protein at the 
renal level, with dysfunction and consequent renal failure. 
The combined transplantation of solid organs has evolved in recent 
years, however, with few studies carried out [3]. 
Regarding the CLKT, particular attention should be paid to the type 
and dose of immunosuppression used in order to reduce the nephrotoxic 
effects and the risk of infection as to not compromise the viability of the 
pulmonary and renal grafts, especially taking into account the use of 
calcineurin-inhibiting drugs. In this case, it was tacrolimus, and the 
main indication for kidney transplantation in lung transplant patients is 
the nephrotoxicity caused by this type of immunosuppressant [4]. On 
the other hand, the detailed control of water balance is fundamental in 
the management between risk of renal dysfunction due to dehydration 
and the risk of pulmonary edema due to excess fluid accumulation. 
According to Reich et al. [3] and Cassuto et al. [5], patient survival after 
CLKT was similar to isolated lung transplantation, and Otani et al. [6] 
showed that CLKT significantly increased life expectancy, preserved 
lung function, and improved the quality of life, which suggests that 
CLKT is a feasible therapeutic option for lung transplantation candidates 
with significant renal dysfunction. 
The authors would like to highlight the extreme complexity of the 
patient and the extreme severity of her clinical condition at the time of 
the transplant and in the following weeks that she was hospitalized. In 
fact, it was the first time in our center that a patient has undergone a 
transplant and has been on VV-ECMO, CCVDHF and invasive mechan-
ical ventilation concurrently and for so long. The recipient’s youth, as 
well as the good conditions of the pulmonary graft, together with an 
experienced multidisciplinary team, certainly helped in the successful 
outcome of this case. 
In conclusion, CLKT may be indicated in carefully selected lung 
transplantation candidates with end-stage renal disease, as long as it is 
possible to proceed with kidney transplantation, ideally at the same 
operative time. 
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Fig. A1. Coronal plane of computerized tomography in June 2016.  
Fig. A2. Axial planes of computerized tomography in June 2016.  
Fig. B1. Coronal plane of computerized tomography at the time of ICU admission in October 2018.   
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Fig. B2. Axial planes of computerized tomography at the time of ICU admission in October 2018.  
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